Home » Topics » Disease categories and therapies » Dental

Dental
RSS

ZymoGenetics and BioMimetic establish agreement for rhPDGF clinical development

June 6, 2001

Atrix's periodontal disease treatment approved in several European countries

May 8, 2001

OraPharma launches Arestin in the U.S. for adjunctive treatment of periodontal disease

April 6, 2001

OraPharma's Arestin cleared for U.S. launch

Feb. 20, 2001

FDA approves tablet formulation of CollaGenex's Periostat

Feb. 6, 2001

U.K. MCA grants marketing clearance for Periostat tablets

Jan. 5, 2001

Aphios awarded grant for antiplaque research

Nov. 8, 2000

Periostat now available in the U.K., its first European market

Oct. 10, 2000

Atrisorb barrier with doxycycline approved by FDA

Sep. 18, 2000

Taro to market and distribute Periostat in Israel

Aug. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...